CMO Pharma-Bio Industry Capital Project Activity Continues to Soar
CMO Pharma-Bio Industry Capital Project Activity Continues to Soar
Attachment: Map
SUGAR LAND--November 23, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Contract Manufacturing Organizations (CMOs) already were an important factor in the drug industry's toolbox pre-COVID, but the enormous demand generated by the pandemic catapulted their value even higher. They responded by boosting capacity and going to 24/7 shifts where possible.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
- Medical Devices & Equipment Sector Brings Billions in Spending to the U.S.
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
